B
Biocytogen Pharmaceuticals Beijing Co Ltd
HKEX:2315
Biocytogen Pharmaceuticals Beijing Co Ltd
HKEX:2315
Price:
15.26
HKD
-0.52%
Market Cap:
6.1B
HKD
Cash Flow Statement
Cash Flow Statement
Biocytogen Pharmaceuticals Beijing Co Ltd
Biocytogen Pharmaceuticals Beijing Co Ltd
Currency: CNY
Millions
TTM
| Jun-2023 | Dec-2023 | Jun-2024 | ||
|---|---|---|---|---|
| Operating Cash Flow | ||||
| Net Income |
0
|
(380)
|
0
|
|
| Depreciation & Amortization |
0
|
182
|
0
|
|
| Other Non-Cash Items |
0
|
131
|
0
|
|
| Cash Taxes Paid |
0
|
1
|
4
|
|
| Cash Interest Paid |
23
|
24
|
29
|
|
| Change in Working Capital |
(210)
|
(10)
|
(29)
|
|
| Cash from Operating Activities |
(210)
N/A
|
(77)
+63%
|
(29)
+62%
|
|
| Investing Cash Flow | ||||
| Capital Expenditures |
(194)
|
(127)
|
(59)
|
|
| Other Items |
(6)
|
26
|
17
|
|
| Cash from Investing Activities |
(201)
N/A
|
(100)
+50%
|
(42)
+58%
|
|
| Financing Cash Flow | ||||
| Net Issuance of Common Stock |
(28)
|
(8)
|
0
|
|
| Net Issuance of Debt |
155
|
147
|
140
|
|
| Other |
469
|
(177)
|
(213)
|
|
| Cash from Financing Activities |
597
N/A
|
(38)
N/A
|
(73)
-92%
|
|
| Change in Cash | ||||
| Effect of Foreign Exchange Rates |
17
|
3
|
(4)
|
|
| Net Change in Cash |
203
N/A
|
(211)
N/A
|
(149)
+30%
|
|
| Free Cash Flow | ||||
| Free Cash Flow |
(404)
N/A
|
(203)
+50%
|
(88)
+57%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
